Dr. Saqib Khan
Angina Pectoris: Its Types, Diagnosis, Pathophysiology & How to Treat it

Angina pectoris, commonly known as angina, is a medical condition characterized by chest pain or discomfort resulting from insufficient blood flow to the heart muscle. This condition is often a symptom of coronary artery disease (CAD), the most common type of heart disease.

Angina can be a distressing experience and may serve as a warning sign of a potential heart attack. Recognizing the types and symptoms of angina is crucial for timely diagnosis and effective management.

In this article, we will discuss in detail about Angina Pectoris: Its Types, Diagnosis, Pathophysiology & How to Treat it.

What is Angina Pectoris?

Angina pectoris occurs when the heart muscle (myocardium) doesn’t receive enough oxygen-rich blood, particularly during times of physical exertion or emotional stress. The inadequate blood supply is usually due to narrowed or blocked coronary arteries, which impede the flow of blood to the heart. The resulting chest pain is often described as squeezing, pressure, heaviness, or tightness in the chest. Sometimes, the pain can radiate to the shoulders, arms, neck, jaw, or back.

Types of Angina Pectoris

Angina pectoris can be classified into several types, each with distinct characteristics and implications for treatment. Understanding these types helps in identifying the appropriate medical intervention and lifestyle changes necessary for managing the condition effectively.

Angina Pectoris: Its Types, Diagnosis, Pathophysiology & How to Treat it

1. Stable Angina or Exertional Angina:

Commonly known as stable angina or exertional angina, this type of chest pain arises due to reduced blood flow to the heart muscle, especially during physical activity or emotional stress. Unlike other forms of angina, stable angina follows a predictable pattern, allowing for effective management with lifestyle changes and medical treatment. Understanding its causes, symptoms, pathophysiology, and treatment options is crucial for mitigating risks and improving quality of life.

 

Causes of Stable Angina

Stable angina is primarily caused by atherosclerosis, a condition where fatty deposits (plaques) build up in the coronary arteries, narrowing them and restricting blood flow to the heart muscle. Key factors contributing to atherosclerosis and, consequently, stable angina include:


  1. High Cholesterol: Elevated levels of LDL (low-density lipoprotein) cholesterol can lead to plaque formation in the arteries.
  2. Hypertension: High blood pressure damages the arterial walls, promoting plaque buildup.
  3. Smoking: Tobacco use accelerates atherosclerosis and decreases oxygen supply to the heart.
  4. Diabetes: High blood sugar levels contribute to arterial damage and plaque formation.
  5. Sedentary Lifestyle: Lack of physical activity increases the risk of cardiovascular disease.
  6. Obesity: Excess weight is associated with higher cholesterol, blood pressure, and diabetes risk.
  7. Family History: Genetic predisposition plays a significant role in developing coronary artery disease.

Signs and Symptoms of Stable Angina

Stable angina presents with characteristic symptoms that are generally predictable and occur during physical exertion or emotional stress. These symptoms include:

  • Chest Pain or Discomfort: Typically described as pressure, squeezing, or heaviness in the chest.
  • Radiating Pain: Pain may extend to the shoulders, arms (usually the left), neck, jaw, or back.
  • Shortness of Breath: Difficulty breathing or feeling out of breath during physical activity.
  • Nausea: Feeling nauseous or lightheaded during an angina episode.
  • Fatigue: Unusual tiredness or lack of energy.

These symptoms usually last for a few minutes and are relieved by rest or nitroglycerin.

Pathophysiology of Stable Angina

The pathophysiology of stable angina involves the interplay between myocardial oxygen demand and supply. Key points include:

Angina Pectoris: Its Types, Diagnosis, Pathophysiology & How to Treat it

  1. Myocardial Oxygen Demand: Physical exertion, emotional stress, or heavy meals increase the heart’s need for oxygen. Factors influencing oxygen demand include heart rate, contractility, and myocardial wall tension.
  2. Myocardial Oxygen Supply: Oxygen is supplied to the heart through the coronary arteries. In stable angina, atherosclerotic plaques narrow these arteries, limiting blood flow. While the heart may receive adequate oxygen at rest, increased demand during exertion exceeds the limited supply, resulting in ischemia (reduced blood flow).
  3. Ischemia and Pain: The reduced oxygen supply to the myocardium leads to anaerobic metabolism and the accumulation of metabolic byproducts like lactic acid. This triggers pain receptors, causing the characteristic chest pain of angina.

Medications for Stable Angina

The primary goals of medication therapy for stable angina are to relieve symptoms, prevent angina attacks, and reduce the risk of heart attacks. The main classes of drugs used include nitrates, beta-blockers, calcium channel blockers, antiplatelet agents, statins, and angiotensin-converting enzyme (ACE) inhibitors.

  1. Nitrates

Nitrates help to dilate (widen) the blood vessels, increasing blood flow to the heart muscle and reducing the heart’s workload. They are commonly used for both acute relief of angina symptoms and long-term prevention.

  • Nitroglycerin (Sublingual Tablets or Spray):
    • Dosage: 0.3 to 0.6 mg sublingually (under the tongue) as needed for chest pain. Can be repeated every 5 minutes for up to three doses.
    • Usage: For acute relief of angina symptoms. If pain persists after three doses, seek emergency medical attention.
  • Isosorbide Mononitrate (Oral Tablets):
    • Dosage: 20 mg twice daily, taken 7 hours apart to minimize tolerance. Extended-release formulations are also available.
    • Usage: For long-term prevention of angina attacks.
  1. Beta-Blockers

Beta-blockers decrease heart rate and contractility, reducing myocardial oxygen demand and preventing angina attacks.

  • Atenolol:
    • Dosage: 50 to 100 mg once daily.
    • Usage: Long-term prevention of angina attacks and reduction of cardiovascular risk.
  • Metoprolol:
    • Dosage: 50 to 100 mg twice daily (immediate-release) or 100 to 200 mg once daily (extended-release).
    • Usage: Long-term management of stable angina.
  1. Calcium Channel Blockers

Calcium channel blockers relax blood vessels and increase blood supply to the heart, reducing angina symptoms. They are particularly useful in patients who cannot tolerate beta-blockers.

  • Amlodipine:
    • Dosage: 5 to 10 mg once daily.
    • Usage: Long-term prevention of angina attacks.
  • Diltiazem:
    • Dosage: 120 to 180 mg once daily (extended-release).
    • Usage: For both prevention and relief of angina symptoms.
  1. Statins

Statins lower cholesterol levels, stabilizing atherosclerotic plaques and reducing the risk of heart attacks.

  • Atorvastatin:
    • Dosage: 10 to 80 mg once daily.
    • Usage: Long-term management to lower LDL cholesterol and reduce cardiovascular risk.
  • Rosuvastatin:
    • Dosage: 5 to 40 mg once daily.
    • Usage: For patients with high cholesterol and increased risk of cardiovascular events.

2. Unstable Angina:

Unstable angina is a critical condition that represents a significant escalation from stable angina. It is characterized by unexpected chest pain or discomfort that occurs at rest or with minimal exertion and is not relieved by rest or standard angina medications. This form of angina indicates a high risk of a heart attack and requires immediate medical attention.


Causes of Unstable Angina

Unstable angina is primarily caused by the acute reduction in blood flow to the heart muscle due to coronary artery disease (CAD). The underlying mechanisms include:

  1. Atherosclerosis: The buildup of fatty deposits (plaques) within the coronary arteries is a common cause. These plaques can rupture, leading to the formation of a blood clot that partially or completely obstructs the artery.
  2. Blood Clots: The rupture of an atherosclerotic plaque can trigger the formation of a thrombus (blood clot), which can significantly reduce or block blood flow.
  3. Coronary Artery Spasm: Sudden constriction of a coronary artery can reduce blood flow to the heart muscle. This spasm can be triggered by stress, cold exposure, or drug use (e.g., cocaine).
  4. Microvascular Dysfunction: Problems with the small blood vessels (microvasculature) of the heart can also lead to unstable angina, particularly in individuals without significant large artery disease.

Signs and Symptoms of Unstable Angina

Unstable angina manifests with more severe and unpredictable symptoms compared to stable angina. Key signs and symptoms include:

  • Chest Pain or Discomfort: Often described as pressure, squeezing, or tightness. The pain may be more intense and prolonged than with stable angina.
  • Pain at Rest: Unlike stable angina, pain can occur without physical exertion and may wake the patient from sleep.
  • Radiating Pain: Pain may spread to the shoulders, arms (particularly the left arm), neck, jaw, or back.
  • Prolonged Episodes: Pain or discomfort typically lasts longer than 20 minutes and is not relieved by rest or standard angina medications like nitroglycerin.
  • Dyspnea (Shortness of Breath): Difficulty breathing or shortness of breath, often accompanying chest pain.
  • Nausea and Sweating: Feelings of nausea, sweating, dizziness, or lightheadedness can occur.
  • Increased Frequency and Severity: Symptoms may become more frequent and severe over time, indicating a worsening condition.

Pathophysiology of Unstable Angina

The pathophysiology of unstable angina involves complex interactions between coronary artery disease, plaque instability, and thrombosis. Key elements include:

Angina Pectoris: Its Types, Diagnosis, Pathophysiology & How to Treat it

    1. Plaque Rupture and Thrombosis: Atherosclerotic plaques within the coronary arteries can become unstable and rupture. This rupture exposes the underlying plaque material, triggering the coagulation cascade and leading to thrombus formation. The resulting blood clot can partially or completely obstruct the artery, reducing blood flow to the heart muscle.
    2. Inflammatory Response: Inflammation plays a significant role in plaque instability. Inflammatory cells within the plaque release enzymes that weaken the fibrous cap, making it more prone to rupture. Additionally, inflammatory mediators can increase the activity of platelets and the coagulation system, promoting thrombus formation.
    3. Endothelial Dysfunction: The endothelium (inner lining of blood vessels) in patients with unstable angina is often dysfunctional, contributing to reduced nitric oxide production and impaired vasodilation. This dysfunction enhances the propensity for vasoconstriction and further reduces blood flow.
    4. Microvascular Dysfunction: In some cases, unstable angina can be related to abnormalities in the microvasculature of the heart. These small vessels may not dilate properly in response to increased oxygen demand, leading to ischemia even without significant obstruction in the large coronary arteries.
    5. Myocardial Ischemia: The reduced blood flow caused by plaque rupture, thrombosis, and vasoconstriction leads to myocardial ischemia (insufficient oxygen supply to the heart muscle). The ischemic heart muscle produces metabolites like lactic acid, which stimulate pain receptors and cause the characteristic chest pain of angina.


Medications for Unstable Angina

The primary goals in treating unstable angina are to alleviate chest pain, prevent further thrombus formation, stabilize atherosclerotic plaques, and improve coronary blood flow. The main classes of drugs used include antiplatelet agents, anticoagulants, nitrates, beta-blockers, calcium channel blockers, statins, and angiotensin-converting enzyme (ACE) inhibitors.

  1. Antiplatelet Agents

Antiplatelet agents are critical in preventing platelet aggregation and thrombus formation.

  • Aspirin:
    • Dosage: Initial dose of 162 to 325 mg, followed by a maintenance dose of 75 to 100 mg daily.
    • Mechanism: Inhibits cyclooxygenase-1 (COX-1), reducing thromboxane A2 production and platelet aggregation.
  • Clopidogrel:
    • Dosage: Loading dose of 300 to 600 mg, followed by 75 mg daily.
    • Mechanism: Inhibits the P2Y12 ADP receptor on platelets, preventing activation and aggregation.
  • Ticagrelor:
    • Dosage: Loading dose of 180 mg, followed by 90 mg twice daily.
    • Mechanism: Reversibly inhibits the P2Y12 ADP receptor on platelets, providing potent antiplatelet effects.
  1. Anticoagulants

Anticoagulants help prevent the formation and extension of blood clots.

  • Heparin (Unfractionated Heparin):
    • Dosage: Initial bolus of 60 to 70 units/kg (maximum 5000 units), followed by an infusion of 12 to 15 units/kg/hour (maximum 1000 units/hour), adjusted to maintain an activated partial thromboplastin time (aPTT) of 1.5 to 2 times the control value.
    • Mechanism: Enhances the activity of antithrombin III, inhibiting thrombin and factor Xa.
  • Enoxaparin (Low-Molecular-Weight Heparin):
    • Dosage: 1 mg/kg subcutaneously every 12 hours.
    • Mechanism: Inhibits factor Xa and thrombin, providing anticoagulant effects.
  • Fondaparinux:
    • Dosage: 2.5 mg subcutaneously once daily.
    • Mechanism: Selectively inhibits factor Xa, preventing thrombus formation.
  1. Nitrates

Nitrates are used to relieve chest pain by dilating blood vessels and reducing myocardial oxygen demand.

  • Nitroglycerin (Sublingual or Intravenous):
    • Dosage: 0.3 to 0.6 mg sublingually for immediate relief; for continuous infusion, start with 5 to 10 mcg/min and titrate to relief of pain or blood pressure response.
    • Mechanism: Converts to nitric oxide, which relaxes vascular smooth muscle and dilates arteries and veins, reducing preload and myocardial oxygen demand.
  1. Beta-Blockers

Beta-blockers reduce heart rate and myocardial contractility, decreasing oxygen demand.

  • Metoprolol:
    • Dosage: Initial intravenous dose of 5 mg every 5 minutes up to three doses, followed by 25 to 50 mg orally every 6 to 12 hours.
    • Mechanism: Blocks beta-adrenergic receptors, reducing heart rate, myocardial contractility, and oxygen consumption.
  • Atenolol:
    • Dosage: 50 to 100 mg orally once daily.
    • Mechanism: Similar to metoprolol, with a longer half-life allowing for once-daily dosing.
  1. Calcium Channel Blockers

Calcium channel blockers are used if beta-blockers are contraindicated or if additional control of symptoms is needed.

  • Diltiazem:
    • Dosage: 30 mg orally four times daily, with titration up to 360 mg daily.
    • Mechanism: Inhibits calcium entry into cardiac and smooth muscle cells, reducing myocardial oxygen demand and increasing coronary blood flow.
  • Amlodipine:
    • Dosage: 5 to 10 mg orally once daily.
    • Mechanism: Similar to diltiazem, with a focus on vasodilation of peripheral and coronary arteries.
  1. Statins

Statins lower cholesterol levels and stabilize atherosclerotic plaques, reducing the risk of cardiovascular events.

  • Atorvastatin:
    • Dosage: 40 to 80 mg orally once daily.
    • Mechanism: Inhibits HMG-CoA reductase, lowering LDL cholesterol and stabilizing plaques.
  • Rosuvastatin:
    • Dosage: 20 to 40 mg orally once daily.
    • Mechanism: Similar to atorvastatin, with a higher potency for LDL reduction.

3. Variant (Prinzmetal) Angina:

Variant angina, also known as Prinzmetal angina or vasospastic angina, is a type of chest pain that occurs due to transient spasms in the coronary arteries, leading to a temporary reduction in blood flow to the heart muscle. Unlike stable angina, which is typically triggered by physical exertion or stress, variant angina usually occurs at rest, often in the early morning hours.

Causes of Variant Angina

The primary cause of variant angina is coronary artery spasm, which temporarily reduces blood flow to the heart muscle. Several factors can contribute to these spasms:

  1. Endothelial Dysfunction: Damage or dysfunction of the endothelium (the inner lining of blood vessels) can lead to an imbalance between vasoconstrictors and vasodilators, promoting spasms.
  2. Hyperreactivity of Smooth Muscle Cells: The smooth muscle cells in the coronary arteries may be overly reactive, leading to spontaneous contractions.
  3. Imbalance of Autonomic Nervous System: Increased activity of the parasympathetic nervous system during rest or sleep can trigger coronary artery spasms.
  4. Exposure to Cold: Cold temperatures can induce vasoconstriction, increasing the risk of spasms.
  5. Smoking: Nicotine and other chemicals in cigarettes can contribute to endothelial dysfunction and smooth muscle hyperreactivity.
  6. Drug Use: Certain drugs, such as cocaine and amphetamines, can induce coronary artery spasms.
  7. Genetic Factors: Genetic predisposition may play a role in the susceptibility to coronary artery spasms.

Signs and Symptoms of Variant Angina

Variant angina presents with characteristic symptoms that are distinct from other forms of angina:

  • Chest Pain or Discomfort: Typically described as a squeezing, tightness, or pressure in the chest. The pain can be severe and is usually located behind the sternum.
  • Occurs at Rest: Unlike stable angina, variant angina often occurs at rest and is more common in the early morning hours.
  • Short Duration: Episodes of chest pain are usually brief, lasting from a few minutes to half an hour.
  • Radiating Pain: Pain may radiate to the shoulders, arms, neck, jaw, or back.
  • Associated Symptoms: Patients may experience sweating, nausea, palpitations, and shortness of breath during an angina episode.
  • Transient Nature: Symptoms are typically relieved by nitroglycerin or other vasodilators.

Pathophysiology of Variant Angina

The pathophysiology of variant angina involves complex interactions between vascular smooth muscle cells, endothelial function, and autonomic nervous system regulation:

Angina Pectoris: Its Types, Diagnosis, Pathophysiology & How to Treat it

    1. Coronary Artery Spasm: The hallmark of variant angina is a sudden, intense spasm of the coronary arteries, leading to a temporary reduction in blood flow (ischemia) to the heart muscle. This spasm is not necessarily associated with significant atherosclerotic plaque, although mild to moderate atherosclerosis may be present.
    2. Endothelial Dysfunction: The endothelium plays a crucial role in regulating vascular tone by releasing vasodilators like nitric oxide and prostacyclin, as well as vasoconstrictors like endothelin-1. In variant angina, endothelial dysfunction results in reduced production of vasodilators and increased sensitivity to vasoconstrictors, promoting spasms.
    3. Smooth Muscle Hyperreactivity: The smooth muscle cells in the coronary arteries of patients with variant angina are hyperreactive, responding excessively to stimuli that would normally cause minor vasoconstriction. This hyperreactivity can be due to genetic factors, chronic endothelial dysfunction, or environmental influences such as smoking.
    4. Autonomic Nervous System Imbalance: The autonomic nervous system, particularly the parasympathetic branch, can influence coronary artery tone. Increased parasympathetic activity during rest or sleep can trigger coronary spasms, leading to angina symptoms.
    5. Inflammatory and Oxidative Stress: Chronic inflammation and oxidative stress can exacerbate endothelial dysfunction and smooth muscle hyperreactivity, contributing to the development of coronary artery spasms.


Medications for Variant Angina:

The primary goals in treating variant angina are to prevent coronary artery spasms, relieve chest pain, and improve blood flow to the heart. The main classes of drugs used include calcium channel blockers, nitrates, and adjunctive therapies.

  1. Calcium Channel Blockers

Calcium channel blockers are the cornerstone of treatment for variant angina. They help to relax the coronary arteries, prevent spasms, and increase blood flow to the heart muscle.

  • Amlodipine:
    • Dosage: 5 to 10 mg orally once daily.
    • Mechanism: Inhibits calcium ions from entering vascular smooth muscle and cardiac muscle cells, leading to vasodilation and decreased myocardial oxygen demand.
  • Diltiazem:
    • Dosage: 120 to 360 mg daily, taken in divided doses or as an extended-release formulation.
    • Mechanism: Blocks calcium ion influx in vascular smooth muscle and the myocardium, providing both coronary and peripheral vasodilation.
  • Nifedipine:
    • Dosage: 30 to 60 mg daily, typically as an extended-release formulation.
    • Mechanism: Acts as a potent vasodilator by blocking calcium channels in vascular smooth muscle, reducing arterial spasm and improving blood flow.
  • Verapamil:
    • Dosage: 180 to 480 mg daily, taken in divided doses or as an extended-release formulation.
    • Mechanism: Inhibits calcium ion entry into vascular smooth muscle and cardiac muscle, leading to reduced heart rate, decreased myocardial contractility, and vasodilation.
  1. Nitrates

Nitrates are used to provide immediate relief from angina symptoms by dilating blood vessels and reducing myocardial oxygen demand.

  • Nitroglycerin (Sublingual):
    • Dosage: 0.3 to 0.6 mg sublingually as needed for acute chest pain. May be repeated every 5 minutes for up to three doses.
    • Mechanism: Converts to nitric oxide, which relaxes vascular smooth muscle and dilates arteries and veins, reducing preload and myocardial oxygen demand.
  • Isosorbide Mononitrate (Oral):
    • Dosage: 20 mg twice daily, or 30 to 60 mg once daily for extended-release formulations.
    • Mechanism: Similar to nitroglycerin, it dilates blood vessels and reduces myocardial oxygen consumption.

Angina Pectoris: Its Types, Diagnosis, Pathophysiology & How to Treat it

Diagnosis of Angina:

Initial Evaluation

The diagnosis of angina begins with a thorough initial evaluation, which includes a detailed medical history, physical examination, and assessment of risk factors.

Medical History

During the medical history, the healthcare provider will inquire about:

  • Symptoms: Characteristics of chest pain, including its onset, duration, intensity, location, and what triggers or relieves it.
  • Associated Symptoms: Presence of symptoms like shortness of breath, sweating, nausea, and palpitations.
  • Risk Factors: Personal and family history of heart disease, hypertension, diabetes, smoking, high cholesterol, and lifestyle factors.
  • Previous Medical Conditions: Any prior history of heart conditions, surgeries, or other relevant health issues.

Physical Examination

The physical examination includes:

  • Vital Signs: Checking blood pressure, heart rate, and respiratory rate.
  • Cardiovascular Examination: Listening to the heart for abnormal sounds (murmurs) and assessing the peripheral pulses.
  • Respiratory Examination: Evaluating breath sounds to rule out respiratory causes of chest pain.

Diagnostic Tests

Several tests are used to diagnose angina and assess the extent of coronary artery disease:

Electrocardiogram (ECG or EKG)

  • Purpose: Detects electrical activity of the heart and identifies abnormalities that may indicate ischemia or past heart attacks.
  • Procedure: Electrodes are placed on the chest, arms, and legs to record the heart’s electrical signals.
  • Results: An abnormal ECG can show signs of angina, such as ST-segment depression or T-wave inversion.

Stress Testing

  • Purpose: Evaluates the heart’s response to physical exertion and identifies exercise-induced ischemia.
  • Types:
    • Exercise Stress Test: Patient walks on a treadmill or pedals a stationary bike while heart activity is monitored.
    • Pharmacologic Stress Test: Medications (e.g., dobutamine or adenosine) are used to stimulate the heart in patients unable to exercise.
  • Procedure: Continuous ECG monitoring during the test, with images of the heart taken before and after exercise or medication.
  • Results: Helps determine if there is reduced blood flow to the heart during physical stress.

Echocardiogram

  • Purpose: Uses ultrasound waves to create images of the heart’s structure and function.
  • Types:
    • Resting Echocardiogram: Taken while the patient is at rest.
    • Stress Echocardiogram: Taken during or after stress testing.
  • Procedure: A transducer is placed on the chest to capture images of the heart.
  • Results: Assesses heart muscle function, valve abnormalities, and areas of reduced blood flow.

Coronary Angiography

  • Purpose: Provides detailed images of the coronary arteries to identify blockages or narrowing.
  • Procedure: A catheter is inserted into a blood vessel (usually in the groin or arm) and guided to the coronary arteries. Contrast dye is injected, and X-ray images are taken.
  • Results: Identifies the location and severity of coronary artery blockages, guiding treatment decisions.

Cardiac CT and MRI

  • Cardiac CT Angiography:
    • Purpose: Non-invasive imaging test to visualize the coronary arteries.
    • Procedure: Contrast dye is injected, and a CT scanner takes detailed images of the heart.
    • Results: Detects coronary artery disease and evaluates the heart’s structure.
  • Cardiac MRI:
    • Purpose: Provides detailed images of the heart’s structure and function using magnetic resonance imaging.
    • Procedure: The patient lies in an MRI scanner while images are captured.
    • Results: Assesses heart muscle damage, scarring, and blood flow.

Blood Tests

Blood tests can help diagnose angina and assess the risk of heart disease:

  • Cardiac Biomarkers:
    • Purpose: Detects markers of heart muscle damage (e.g., troponins) in the blood.
    • Results: Elevated levels indicate myocardial injury or infarction.
  • Lipid Profile:
    • Purpose: Measures cholesterol levels, including LDL, HDL, and triglycerides.
    • Results: Helps assess the risk of coronary artery disease.
  • Other Tests:
      • C-Reactive Protein (CRP): Measures inflammation levels in the body, which can indicate increased risk of heart disease.
      • Blood Glucose: Evaluates diabetes or prediabetes, which are risk factors for coronary artery disease.


Also Read: 

Video Guide:

Conclusion:

Angina, characterized by chest pain due to reduced blood flow to the heart, encompasses various forms, including stable, unstable, and variant (Prinzmetal’s) angina. Effective management involves identifying the specific type, addressing underlying causes, and implementing appropriate treatment strategies. Lifestyle modifications, medication adherence, and regular medical follow-ups are essential in managing symptoms and preventing complications. By staying informed and proactive in managing heart health, individuals with angina can improve their quality of life and reduce the risk of severe cardiovascular events. For more detailed information and updates on heart health, subscribe to our blog and stay informed about the latest advancements in cardiovascular care.

By Dr. Saqib Khan

I am a medical professional and research scholar having vast experience in Computer-aided drug discovery and organic Synthetic Chemistry. I also have a passion for academic and medical writing.

Leave a Reply

Your email address will not be published. Required fields are marked *